Why is Roivant Sciences Ltd. ?
- NET SALES(Q) At USD 2 MM has Fallen at -60.67%
- ROCE(HY) Lowest at -17.11%
- OPERATING PROFIT(Q) Lowest at USD -338.46 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 177.54%, its profits have fallen by -122%
- Promoters have decreased their stake in the company by -3.21% over the previous quarter and currently hold 8.44% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Roivant Sciences Ltd. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD -759.08 MM
Higher at USD -484.13 MM
Lowest at -103.62 %
At USD 2 MM has Fallen at -60.67%
Lowest at -17.11%
Lowest at USD -338.46 MM
Lowest at USD -287.55 MM
Grown by 60.55% (YoY
Lowest at 0 times
Lowest at 0.19 times
Lowest at USD -263.07 MM
Lowest at USD -0.38
Here's what is working for Roivant Sciences Ltd.
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Here's what is not working for Roivant Sciences Ltd.
Net Sales (USD MM)
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Inventory Turnover Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales






